Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 07, 2024

SELL
$145.54 - $178.83 $28,380 - $34,871
-195 Reduced 9.79%
1,796 $311,000
Q1 2024

Apr 29, 2024

SELL
$165.67 - $199.94 $42,080 - $50,784
-254 Reduced 11.31%
1,991 $336,000
Q4 2023

Feb 02, 2024

BUY
$151.44 - $200.09 $5,603 - $7,403
37 Added 1.68%
2,245 $443,000
Q3 2023

Oct 20, 2023

BUY
$167.14 - $192.77 $1,504 - $1,734
9 Added 0.41%
2,208 $384,000
Q2 2023

Jul 19, 2023

BUY
$160.94 - $186.23 $65,019 - $75,236
404 Added 22.51%
2,199 $378,000
Q1 2023

Apr 25, 2023

SELL
$145.48 - $175.02 $7,273 - $8,751
-50 Reduced 2.71%
1,795 $298,000
Q4 2022

Jan 31, 2023

BUY
$131.14 - $157.47 $655 - $787
5 Added 0.27%
1,845 $270,000
Q3 2022

Oct 17, 2022

SELL
$148.29 - $182.55 $5,635 - $6,936
-38 Reduced 2.02%
1,840 $273,000
Q2 2022

Jul 28, 2022

SELL
$155.97 - $200.09 $13,881 - $17,808
-89 Reduced 4.52%
1,878 $323,000
Q1 2022

Apr 27, 2022

SELL
$181.39 - $234.03 $207,147 - $267,262
-1,142 Reduced 36.73%
1,967 $371,000
Q4 2021

Feb 07, 2022

SELL
$193.69 - $247.03 $15,301 - $19,515
-79 Reduced 2.48%
3,109 $759,000
Q3 2021

Oct 25, 2021

SELL
$189.29 - $209.69 $126,824 - $140,492
-670 Reduced 17.37%
3,188 $619,000
Q2 2021

Jul 27, 2021

BUY
$155.9 - $187.99 $7,327 - $8,835
47 Added 1.23%
3,858 $719,000
Q1 2021

Apr 09, 2021

BUY
$144.0 - $169.39 $548,784 - $645,545
3,811 New
3,811 $600,000
Q4 2020

Jan 14, 2021

SELL
$157.07 - $174.35 $588,227 - $652,940
-3,745 Closed
0 $0
Q3 2020

Oct 20, 2020

SELL
$137.1 - $165.37 $18,645 - $22,490
-136 Reduced 3.5%
3,745 $619,000
Q2 2020

Jul 10, 2020

BUY
$111.92 - $142.53 $7,386 - $9,406
66 Added 1.73%
3,881 $532,000
Q1 2020

Apr 10, 2020

BUY
$92.66 - $144.94 $4,633 - $7,247
50 Added 1.33%
3,815 $449,000
Q4 2019

Jan 14, 2020

BUY
$116.25 - $133.25 $48,825 - $55,965
420 Added 12.56%
3,765 $498,000
Q3 2019

Oct 17, 2019

BUY
$112.57 - $128.43 $376,546 - $429,598
3,345 New
3,345 $417,000

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $82.7B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Fulton Breakefield Broenniman LLC Portfolio

Follow Fulton Breakefield Broenniman LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fulton Breakefield Broenniman LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fulton Breakefield Broenniman LLC with notifications on news.